Prolonged allograft survival in TNF receptor 1-deficient recipients is due to immunoregulatory effects, not to inhibition of direct antigraft cytotoxicity

Journal of Immunology

Volumn 168, Issue 1, 2002, Pages 483-489

  McKee, C M ^a   Defina, R ^a   He, H ^a   Haley, K J ^a   Stone, J R ^a   Perkins, D L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LYMPHOTACTIN; LYMPHOTOXIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; GENE DELETION; GENE EXPRESSION; GENE MAPPING; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0036135556     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.1.483     Document Type: Article

References (43)

1. Cytokines as mediators of organ graft rejection and tolerance
2. Tumour necrosis factor α and the cardiovascular system: Its role in cardiac allograft rejection and heart disease
3. The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-α predict rejection following orthotopic liver transplantation
4. Expression of tumor necrosis factor in human acute cardiac rejection: An immunohistochemical and immunoblotting study
5. Renal allograft rejection: The temporal relationship and predictive value of plasma TNF (α and β), IFN-γ and soluble ICAM-1
6. Tumor necrosis factor-β is associated with thymic apoptosis during acute rejection
7. Induction of TNF α and TNF β gene expression in rat cardiac transplants during allograft rejection
8. Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac grafts
9. Cytokine gene expression in rejecting cardiac allografts
10. Anti-tumor necrosis factor antibody enhances allograft survival in rats
11. The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-α and lymphotoxin enhances cardiac allograft survival in rats
12. The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection
13. The TNF and TNF receptor superfamilies: Integrating mammalian biology
14. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
15. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
16. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling
17. Lymphotoxin-alpha-deficient and TNF receptor-1-deficient mice define developmental and functional characteristics of germinal centers
18. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers
19. Role of tumor necrosis factor receptors TNFR-I (P55) and TNFR-II (P75) in corneal transplantation
20. K, and non-H-2 antigens in rejection
21. Differential expression of activation markers during tolerance induction by superantigens in T-cell receptor (β-chain) transgenic mice
22. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group: The International Society for Heart Transplantation
23. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
24. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
25. The p55 TNF-α receptor plays a critical role in T cell alloreactivity
26. New insights into the biology of the acute phase response
27. Increased expression of inflammatory cytokines and adhesion molecules by alveolar macrophages of human lung allograft recipients with acute rejection: Decline with resolution of rejection
28. Circulating interleukin-1 receptor antagonist (IL-1RA) serum levels in patients undergoing orthotopic heart transplantation
29. Endogenous interleukin I receptor antagonist during human bone marrow transplantation: Increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy
30. On the edge: The physiological and pathophysiological role of chemokines during inflammatory and immunological responses
31. Chemokines and their receptors in allograft rejection
32. Lymphotactin: A key regulator of lymphocyte trafficking during acute graft rejection
33. Donor-derived IP-10 initiates development of acute allograft rejection
34. Expression of chemokines and chemokine receptors during human renal transplant rejection
35. RANTES chemokine expression in cell-mediated transplant rejection of the kidney
36. RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages
37. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy
38. + T cells
39. IFN-γ-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy
40. + T cells produce RANTES during acute rejection of murine allogeneic skin grafts
41. Molecular cloning and functional characterization of human lymphotactin
42. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease
43. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection